Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Please take
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Please take
Spanish patients with various forms of inflammatory arthritis who started either etanercept or adalimumab were more likely to continue taking them if they were biosimilar
The American College of Physicians (ACP) updated guidance reaffirming its stance that colorectal cancer screening should wait until age 50 for average-risk, asymptomatic adults. The